Repurposed GI Drugs in the Treatment of COVID-19
- PMID: 32601778
- PMCID: PMC7324004
- DOI: 10.1007/s10620-020-06430-z
Repurposed GI Drugs in the Treatment of COVID-19
Conflict of interest statement
The authors declare that they have no conflict of interest.
Comment on
-
Clinical Insights into the Gastrointestinal Manifestations of COVID-19.Dig Dis Sci. 2020 Jul;65(7):1932-1939. doi: 10.1007/s10620-020-06362-8. Epub 2020 May 23. Dig Dis Sci. 2020. PMID: 32447742 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
